Clover Health Investments (CLOV) Delivers Strong Revenue Growth in Q4 2025 Amid Path to Profitability
“Clover Health reported Q4 2025 total revenues of approximately $488 million, marking a roughly 45% year-over-year increase and surpassing analyst expectations. The company posted a GAAP net loss but achieved full-year Adjusted EBITDA profitability of $22 million for 2025, with Medicare Advantage membership climbing 38% to over 113,000. Despite ongoing industry cost pressures, medical trends … Read more